Publications by authors named "Chisa Nakashima"

Article Synopsis
  • - Atopic dermatitis (AD) is influenced by immune dysregulation, barrier dysfunction, and itching, with various immune cells and cytokines playing key roles in its development and progression.
  • - Current treatments like Dupilumab and Nemolizumab target specific cytokines related to Th2 responses and itching, showing effectiveness in moderate to severe cases of AD.
  • - Some potential therapies targeting cytokines like IL-33 and TSLP have not proven effective in clinical trials, highlighting the need for targeted treatment strategies based on disease severity and phase.
View Article and Find Full Text PDF
Article Synopsis
  • The integumentary system, particularly the stratum corneum, acts as a key protective barrier for the skin, with keratinocytes producing filaggrin (Flg) essential for skin health; however, the role of sensory nerves in the skin's recovery process after damage remains unclear.
  • This study aimed to explore how sensory nerves contribute to the repair of the skin barrier post tape stripping, using a mouse model to analyze nerve activity, skin recovery rates, and the involvement of specific neuropeptides.
  • Results indicated that TRPV1-positive sensory nerves are crucial for skin barrier recovery, as their absence led to inflammation and reduced production of Flg; treatment with somatostatin showed potential in improving barrier recovery, highlighting
View Article and Find Full Text PDF
Article Synopsis
  • In December 2019, SARS-CoV-2 was identified as the virus causing COVID-19, which mainly leads to respiratory issues but also has various skin manifestations.
  • These skin reactions can be categorized into seven types, including chilblain-like lesions and urticaria, and may arise due to the virus itself or as reactions to COVID-19 vaccinations.
  • Future research is needed to better understand the mechanisms behind these skin reactions and establish clear causal relationships between them and COVID-19 or the vaccines.
View Article and Find Full Text PDF

A decrease in the number of basophils in the peripheral blood, or basopenia, has been noted, reflecting the activity of chronic spontaneous urticaria (CSU). Infiltration of basophils into the skin has also been reported, but the mechanism of basopenia in CSU has not been clarified. The phenomenon of basopenia during the active phase of urticaria was confirmed, and basophil numbers increased following symptom improvement in 15 out of 17 patients treated with omalizumab and in 13 of 15 patients treated with antihistamines.

View Article and Find Full Text PDF

Atopic dermatitis (AD) is characterized by chronic, eczematous, severe pruritic skin lesions. The knowledge on the pathogenesis of AD is driving the development of new drugs. From the research results, it has been revealed that Th2 cell-mediated immunity, skin barrier dysfunction, and pruritus cause a vicious cycle of AD.

View Article and Find Full Text PDF

Background: Sensory nerves regulate cutaneous local inflammation indirectly through induction of pruritus and directly by acting on local immune cells. The underlying mechanisms for how sensory nerves influence cutaneous acquired immune responses remain to be clarified.

Objective: This study aimed to explore the effect of peripheral nerves on cutaneous immune cells in cutaneous acquired immune responses.

View Article and Find Full Text PDF

Immune checkpoint inhibitors have improved the prognosis of advanced melanoma. Although anti-programmed death ligand-1 (PD-L1) is a well-studied biomarker for response to anti-programmed death-1 PD-1 therapy in melanoma, its clinical relevance remains unclear. It has been established that the high expression of indoleamine 2,3-dioxygenase (IDO) is correlated to a response to anti-CTLA-4 treatment in melanoma.

View Article and Find Full Text PDF

Mast cells, eosinophils and basophils are central effector immune cells in allergic skin inflammation including atopic dermatitis (AD). Recent studies revealed that the bidirectional interaction between these three immune cell types (mast cells, eosinophils and basophils) and the nervous system is involved in the pathogenesis of neurogenic inflammation, pain and pruritus. Emerging evidence shows that these cells are the main source of pruritogens such as histamine, neuropeptides and cytokines, which are potential new therapeutic targets for drug development in chronic pruritus.

View Article and Find Full Text PDF

Cancer immunotherapy has highlighted the clinical relevance of enhancing anti-tumor response of CD8+ T cells in several cancer types. Little is known, however, about the involvement of the immune system in extramammary Paget's disease (EMPD). We examined the cytotoxicity and the effector functions of CD8+ T cells using paired samples of peripheral blood and tumors by flow cytometry.

View Article and Find Full Text PDF

Immune checkpoint blockade (ICB) induces a remarkable response in patients with certain cancers. However, the response rate is not yet satisfactory. Biomarkers that help physicians identify patients who would benefit from ICB need to be developed.

View Article and Find Full Text PDF

Basophils have been recognized as crucial players in allergic inflammation. Basophils have the potential to initiate and expand inflammation through the production of specific cytokines and proteases, and are associated with T helper 2 (Th2) immune responses. In addition, recent studies revealed the heterogeneity in basophil populations.

View Article and Find Full Text PDF
Article Synopsis
  • Atopic dermatitis (AD) is a chronic skin condition marked by itchy, eczematous lesions due to skin barrier issues and an immune response mediated by T helper (Th)2 cells.
  • The cytokine interleukin (IL)-31, mainly produced by Th2 cells, plays a key role in causing itchiness and has been linked to the development of AD-like symptoms in both IL-31 transgenic mice and normal mice treated with IL-31.
  • Recent studies have shown that targeting the IL-31 receptor with an anti-IL-31 receptor antibody can significantly reduce itchiness in patients suffering from AD, highlighting the importance of IL-31 and its receptor in the condition.
View Article and Find Full Text PDF

Mast cells and basophils play a pathogenetic role in allergic, inflammatory, and autoimmune disorders. These cells have different development, anatomical location and life span but share many similarities in mechanisms of activation and type of mediators. Mediators secreted by mast cells and basophils correlate with clinical severity in asthma, chronic urticaria, anaphylaxis, and other diseases.

View Article and Find Full Text PDF

Atopic dermatitis (AD) is a common chronic skin inflammatory disorder characterized by recurrent eczema accompanied by an intractable itch that leads to an impaired quality of life. Extensive recent studies have shed light on the multifaceted pathogenesis of the disease. The complex interplay among skin barrier deficiency, immunological derangement, and pruritus contributes to the development, progression, and chronicity of the disease.

View Article and Find Full Text PDF

Background: Repetitive frictional trauma can be induced in daily and occupational activities, such as daily ablutions with washcloths. The influence of frictional trauma on the skin barrier function, especially in the perspective of the components of stratum corneum (SC), has not yet been studied in detail. Raman spectroscopy is a noninvasive optical technique based on inelastic light scattering that is capable of measuring several components in the skin.

View Article and Find Full Text PDF
Article Synopsis
  • - Nivolumab improves overall and progression-free survival in melanoma patients, but only 20-40% benefit long-term, highlighting the need for better predictive markers of treatment response.
  • - A study of 46 melanoma patients found that an early increase in Th9 cell counts and higher serum levels of TGF-β before treatment were linked to improved responses to nivolumab.
  • - Th9 cells, which produce IL-9, are suggested to play a significant role in the effectiveness of nivolumab, making them a potential biomarker to enhance anti-PD-1 therapy outcomes.
View Article and Find Full Text PDF